Mcdonald, B. R., Contente-Cuomo, T., Sammut, S., Odenheimer-Bergman, A., Ernst, B., Perdigones, N., . . . Murtaza, M. (2018, September 26). Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis bioRxiv. https://doi.org/10.1101/425470
Chicago Style (17th ed.) CitationMcdonald, Bradon R., et al. "Detection of Residual Disease After Neoadjuvant Therapy in Breast Cancer Using Personalized Circulating Tumor DNA Analysis." BioRxiv 26 Sep. 2018. https://doi.org/10.1101/425470.
MLA (9th ed.) CitationMcdonald, Bradon R., et al. "Detection of Residual Disease After Neoadjuvant Therapy in Breast Cancer Using Personalized Circulating Tumor DNA Analysis." BioRxiv, 26 Sep. 2018, https://doi.org/10.1101/425470.